Incyte to Present at the Oppenheimer 23rd Annual Healthcare Conference

  Incyte to Present at the Oppenheimer 23rd Annual Healthcare Conference

Oppenheimer Healthcare Conference 2012

Business Wire

WILMINGTON, Del. -- November 28, 2012

Incyte Corporation (Nasdaq:INCY) announced today it will present at the
Oppenheimer 23^rd Annual Healthcare Conference on Thursday, December 13 at
1:35 p.m. (EST) in New York.

The presentation will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts. A replay of the presentation
will be available for 90 days. Investors interested in listening to the live
webcast should log on before the start time in order to download any software
required.

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company
focused on the discovery, development and commercialization of proprietary
small molecule drugs for oncology and inflammation. For additional information
on Incyte, please visit the Company's web site at www.incyte.com.

Contact:

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944
 
Press spacebar to pause and continue. Press esc to stop.